Updated privacy policy - GDPR

Updated privacy policy - GDPR

May 24, 2018

We are committed to protecting and safeguarding your personal data. We now meet the high standard for data privacy introduced by the new European data protection law known as the General Data Protection Regulation (GDPR) effective 25 May 2018.

You can review our policy at any time.

Our updated policy explains your rights under this new law, regarding how personal information is stored and processed. If you have any questions please don’t hesitate to contact us directly.

As always, thanks for being a part of our journey to make an impact on human wellbeing.




Also in News

SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide
SAHMRI and Trajan Nutrition sign new agreement to accelerate nutrition testing worldwide

February 17, 2020

Trajan Nutrition has signed a Memorandum of Understanding with the South Australian Health and Medical Research Institute (SAHMRI) to accelerate the translation in the global market of nutrition testing research led by professors Maria Makrides and Robert Gibson.

Read More

Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia
Trajan’s hemaPEN included on TGA’s ARTG as first blood microsampling device for use in Australia

February 07, 2020

Trajan Scientific and Medical’s hemaPEN® device has been included on the Australian Register of Therapeutic Goods (ARTG). The device enables the volumetrically accurate collection and storage of four dried blood spot (DBS) samples remote to the clinical setting, to drive information-rich healthcare decision making.

Read More

Trajan accelerating adoption and growth of microsampling technologies
Trajan accelerating adoption and growth of microsampling technologies

December 06, 2019

Trajan Scientific and Medical announce the appointment of two new roles in their expanding Microsampling business to support global adoption of the portfolio. Led by Dr Anne Collins, the Microsampling business is focused on enabling samples that would not or could not otherwise be taken, to drive information-rich decision making.

Read More